NuCana Announces Proposed Public Offering of American Depositary Shares

EDINBURGH, United Kingdom, Sept. 16, 2020 (GLOBE NEWSWIRE) -- NuCana plc, a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer, announced today that it has commenced an underwritten public offering of its American Depositary Shares (“ADSs”). Each ADS represents one ordinary share of NuCana. In addition, NuCana expects